Quanjie Li Selected Research

mu Opioid Receptors (mu Opioid Receptor)

10/2019

Discovery of Novel Biased Opioid Receptor Ligands through Structure-Based Pharmacophore Virtual Screening and Experiment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quanjie Li Research Topics

Disease

6	Infections 01/2022 - 01/2018
3	COVID-19 12/2021 - 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Human Influenza (Influenza) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Pain (Aches) 10/2019

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2019
2	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2021
2	Viral RNAIBA 08/2021 - 11/2019
1	Pharmaceutical PreparationsIBA 01/2022
1	ElementsIBA 01/2022
1	Retroelements (Retrotransposon)IBA 01/2022
1	Cyclophilin AIBA 01/2022
1	remdesivirIBA 12/2021
1	NucleosidesIBA 06/2021
1	corilaginIBA 06/2021
1	Amino Acids FDA Link 01/2020
1	entrectinibIBA 01/2020
1	Viral DNAIBA 01/2020
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 11/2019
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2019
1	Formaldehyde (Formol)FDA Link 10/2019
1	ArrestinIBA 10/2019
1	InterferonsIBA 01/2018
1	Long Noncoding RNAIBA 01/2018

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2018